http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010086880-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d192a441fff6ab3681d3333d62ea547e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a014c95021f95d3f8d39285e3bf1bcfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5efd9969d263b374e1133376585630c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cc8ea73ae44de862ddbdf379f5c8e23 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 |
| filingDate | 2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88e34d2fc09eb8927e618fc6225f7ae7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0072fe95727b954be2a6572ee6ac53c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28ed3099b2bbfd91b80e61d171fae824 |
| publicationDate | 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2010086880-A2 |
| titleOfInvention | A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
| abstract | The present invention relates to targeted drug delivery of a drug or therapeutic agent through medical devices coated with formulations comprising of therapeutic agent. The coating on medical devices comprises of therapeutic agent(s), affinity vehicle(s) and additives for targeted drug delivery of biologically active material(s). The invention provides a method of manufacturing the formulation, method of coating the medical devices with such formulations to achieve controlled delivery of optimum drug dose at the target site within the body, desirable drug retention on the medical devices in vivo and in vitro and desirable drug release at the target tissue in-vivo. The invention this provides a mechanism to enhance the bioavailability of the therapeutic agent at the target tissue in the treatment of restenosis thereby reduces the actual dose of the therapeutic agent and provides a very thin layer of coating on the surface of the medical device. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892752-A |
| priorityDate | 2009-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1275.